To further define the oncogenic relevance of PHF19 in supporting MM biology, functional studies have been carried out and PHF19-silencing approaches have demonstrated inhibition of MM cell cycle progression, reduction of MM cell proliferation and survival [47], thus recapitulating the importance for PHF19 in supporting MM pathogenesis and disease progression. This evidence concerns the gene PHF19 and Miyoshi myopathy.